Furthermore, a higher expression of miR-509-3p within the NAT tissues was associated with a progressive disease, recurrence, and early death in CRC patients, highlighting the importance of this miRNA as a potentially predictive biomarker of poor prognosis in CRC. The gene discussed is BRD2; the disease is colorectal carcinoma.